Clinical Trial Update: As a Second-line Treatment for Metastatic Gastric Adenocarcinoma Patients, the Safety and Effective of Vactosertib Administration in Combination With Paclitaxel+Ramucirumab is Evaluated, and a Phase 2a Clinical Trial to Biomarkers [Phase 2]

View source ↗

Summary

Phase 2a trial evaluating safety and efficacy of Vactosertib with paclitaxel and ramucirumab as a second-line treatment for metastatic gastric adenocarcinoma, w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gastric Adenocarcinoma
• Gastric Cancer

Drugs mentioned

• PACLITAXEL (PACLITAXEL)
• Ramucirumab (ramucirumab)
• Vactosertib (Vactosertib)

Snippet

Sponsor: Samsung Medical Center | Conditions: Gastric Cancer | Phase 2 | Status: UNKNOWN